News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nvidia and Firmus struck a deal to deliver 170,000 GPUs to Batam between 2027 and 2028, expanding global AI compute capacity.
  • Austria urged the EU to study hosting Anthropic after U.S. restrictions limited foreign access to its advanced AI models.
  • Twin earthquakes in Venezuela killed over 1,400 and left tens of thousands unaccounted amid aftershocks and scarce heavy equipment.
  • Thousands plan more protests in Serbia after President Vučić said he would resign, keeping pressure for early elections.
  • United Russia placed a wounded Ukraine war veteran, a state TV correspondent, and senior officials atop its September parliamentary candidate list.
  • Herc Holdings touted post-H&E acquisition scale and a 7.1 EV/EBITDA as a basis for a disciplined long trade.
  • Cerebras flagged as a buyable pullback after 94% year‑over‑year revenue growth and a major OpenAI deal amid high volatility.

Latest Articles

FutureFuel Announces Director Resignation

FutureFuel Announces Director Resignation

FutureFuel Corp. disclosed that Paul M. Manheim, a long-serving board member and chair of the Audit Committee, will retire from the Board effective after the 2026 annual meeting. This resignation was not due to any disagreement with the company. Consequently, the Board will reduce its size from nine to eight members and is reviewing its committee c…

Zscaler CFO Kevin Rubin Offloads $372,669 in Shares Amid Market Volatility

Zscaler CFO Kevin Rubin Offloads $372,669 in Shares Amid Market Volatility

Zscaler, Inc. (NASDAQ: ZS) Chief Financial Officer Kevin Rubin executed the sale of 3,000 shares on June 25, 2026, realizing proceeds totaling $372,669. The transactions were conducted under a Rule 10b5-1 trading plan established in March 2026, with share prices varying between $123.1793 and $126.79. This insider activity takes place against a back…

Kite Realty Group Completes Sale of City Center

Kite Realty Group Completes Sale of City Center

Kite Realty Group (NYSE: KRG) announced the successful sale of City Center, a mixed-use asset in White Plains, New York, for $50 million. This sale advances its capital recycling goals and aligns with previously shared plans. The company will detail use of proceeds and future capital allocation plans in the upcoming earnings call. With a focus on h…

Figure Technology CFO Executes Pre-Arranged Stock Sale

Figure Technology CFO Executes Pre-Arranged Stock Sale

Kgil Minchung, Chief Financial Officer of Figure Technology Solutions, Inc. (FIGR), executed a series of stock sales totaling $110,572 on June 24, 2026. The transactions were conducted through a Rule 10b5-1 trading plan established in late 2025. The sale occurred against a backdrop of robust corporate performance, including a significant Q1 earning…

CarMax Director O’Neil Executes $502,656 Stock Acquisition

CarMax Director O’Neil Executes $502,656 Stock Acquisition

CarMax Inc. (NASDAQ:KMX) director Mark F. O’Neil completed a $502,656 acquisition of the company’s common stock on June 24, 2026, purchasing shares at $52.36 each. The transaction, split between direct holdings and a family irrevocable trust, occurs as KMX trades near $52.70 with a $7.43 billion market capitalization. This executive buying activity…

Kite Realty Group Publishes Annual Corporate Responsibility Report

Kite Realty Group Publishes Annual Corporate Responsibility Report

Kite Realty Group, a real estate investment trust specializing in open-air shopping centers and mixed-use assets, published its 2025 Corporate Responsibility Report detailing its strategies, initiatives, and progress on corporate responsibility. The report underscores the company’s commitment to sustainability and stakeholder value across its U.S.-…

MGIC Investment CFO Executes Pre-Arranged Sale Amid Mixed Q1 Results

MGIC Investment CFO Executes Pre-Arranged Sale Amid Mixed Q1 Results

MGIC Investment Corp (MTG) CFO Nathaniel H. Colson sold 20,000 shares for $542,000 on June 25, 2026, under a pre-arranged trading plan. The transaction occurs as the mortgage insurer reports a Q1 2026 EPS beat of $0.76 against $0.74 expectations, yet misses revenue targets at $297.08 million versus $303.22 million. RBC Capital initiated coverage wi…

Alpex Acquisition Completes $115 Million IPO; Units Begin Trading on Nasdaq

Alpex Acquisition Completes $115 Million IPO; Units Begin Trading on Nasdaq

Alpex Acquisition Corporation closed an initial public offering of 11,500,000 units at $10.00 per unit, raising $115,000,000 including the full exercise of the underwriters' over-allotment option, the company said in a press release. Units began trading on the Nasdaq Global Market on June 25, 2026. The offering also included a concurrent private pl…

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

Larimar Therapeutics announced an upcoming investor webcast to share updates on their nomlabofusp clinical program for treating Friedreich’s ataxia. The event will cover regulatory progress and data from ongoing long-term studies. The company is focused on developing treatments for rare diseases and is advancing nomlabofusp towards regulatory submi…

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Monopar Therapeutics announced new analyses from their Phase 3 FoCus trial demonstrating that ALXN1840 provides significant neurologic and global clinical improvements over standard of care for Wilson Disease patients with neurological symptoms. The data supports a planned FDA New Drug Application submission in mid-2026, highlighting ALXN1840's str…

Alpex Acquisition Corporation Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Over-allotment Option

Alpex Acquisition Corporation Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Over-allotment Option

Alpex Acquisition Corporation, a Cayman Islands exempted blank check company, has successfully closed its initial public offering of 11.5 million units at $10 per unit, including the full exercise of the underwriters' over-allotment option. Gross proceeds totaled $115 million before expenses, with net proceeds held in trust pending a future busines…

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Universe Pharmaceuticals INC, a Nasdaq-listed pharmaceutical company based in China, announced the strategic acquisition of Best Praise International Limited, a company holding five patents related to age-related diseases, neurodegenerative conditions, cardiovascular pharmaceuticals, antibacterial compounds, and drug delivery technologies. The acqu…